The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert about the circulation of counterfeit chlorpheniramine and dexamethasone injections. These medications are widely used for their anti-inflammatory and antihistamine properties.
NAFDAC is urging consumers and healthcare providers to ensure that they purchase these medical products only from authorized or licensed suppliers. The agency stressed the importance of verifying the authenticity and checking the physical condition of these products to prevent the use of counterfeit medications that could endanger health.
The alert serves as a reminder for vigilant procurement practices to safeguard public health against the risks associated with counterfeit drugs.
Source: Read more